In silico prediction of membrane permeability from calculated molecular parameters

Journal of Medicinal Chemistry

Volumn 48, Issue 3, 2005, Pages 805-811

  Refsgaard, Hanne H F ^a   Jensen, Berith F ^b   Brockhoff, Per B ^c   Padkjær, Søren B ^a   Guldbrandt, Mette ^a   Christensen, Michael S ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; FUROSEMIDE; RANITIDINE; TAUROCHOLIC ACID; TESTOSTERONE; VERAPAMIL;

ARTICLE; CELL MEMBRANE PERMEABILITY; COMPUTER MODEL; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; PREDICTION;

ANIMALS; CELL LINE; CELL MEMBRANE PERMEABILITY; DIFFUSION; DOGS; HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 13444250951     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049661n     Document Type: Article

References (46)

1. Boobis, A.; Gundert-Remy, U.; Kremers, P.; Macheras, P.; Pelkonen, O. In Silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15. Eur. J. Pharm. Sci. 2002, 17, 183-193.
2. Ekins, S.; Rose, J. In silico ADME/Tox: the state of the art. J. Mol. Graph. Model. 2002, 20, 305-309.
3. Walters, W. P.; Murcko, M. A. Prediction of 'drug-likeness'. Adv. Drug Delivery Rev. 2002, 54, 255-271.
4. Waterbeemd, H. van de; Gifford, E. ADMET in silico Modelling: Towards prediction paradise? Nature 2003, 2, 192-204.
5. Lombardo, F.; Gifford, E.; Shalaeva, M. Y. In silico ADME prediction: Data, Models, Facts and Myths. Mini Rev. Med. Chem. 2003, 3, 861-875.
6. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
7. Artursson, P.; Palm, K.; Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Delivery Rev. 1996, 22, 67-84.
8. Hidalgo, I. J. Cultured intestinal epithelial cell models. In Models for Assessing Drug Absorption and Metabolism; Borchardt, R. T., Smith, P. L., Wilson, G., Eds.; Plenum: New York, 1996; pp 35-50.
9. Irvine, J. D.; Takahashi, L.; Lockhart, K.; Cheong, J.; Tolan, J. W.; Selick, H. E.; Grove, J. R. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci. 1999, 88, 28-33.
10. Lipinski, C. A.; Lombardo, F.; Dominy B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
11. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernäs, H.; Karlén, A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 1998, 41, 4939-4949.
12. Raevsky, O. A.; Fetisov, V. I.; Trepalina, E. P.; McFarland, J. W.; Schaper, K.-J. Quantitative estimation of drug absorption in humans for passively transported compounds on the basis of their physicochemical parameters. Quant. Struct.-Act. Relat. 2000, 19, 366-374.
13. Agatonovic-Kustrin, S.; Beresford, R.; Pauzi, A.; Yusof, M. Theoretically derived molecular descriptors important in human intestinal absorption. J. Pharm. Biomed. Anal. 2001, 25, 227-237.
14. Faassen, F.; Vogel, G.; Spanings, H.; Vromans, H. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int. J. Pharm. 2003, 263, 113-122.
15. Kelder, J.; Grootenhuis, P. D.; Bayada, D. M.; Delbressine, L. P.; Ploemen, J. P. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm. Res. 1999, 16, 1514-1519.
16. Stenberg, P.; Norinder, U.; Luthman, K.; Artursson, P. Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. 2001, 44, 1927-1937.
17. Yazdanian, M.; Briggs, K.; Jankovsky, C.; Hawi, A. The "High Solubility" Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs. Pharm. Res. 2004, 21, 293-299.
18. Jack, D. B. Handbook of Clinical Pharmacokinetic Data; Macmillan Publishers Ltd., New York, 1992.
19. Physician's Desk Reference, 55th ed.; Medical Economic Co., Montvale, NJ, 2001.
20. Hammarlund-Udenaes, M.; Benet L. Z. Furosemide pharmacokinetics and pharmacodynamics in health and disease -an update. J. Pharmcokin. Biopharm. 1989, 17, 1-46.
21. Guidance for Industry, Waiver of In Vivo Bioavailability and Bioequivalence studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, August 2000, FDA/CDER.
22. Winiwarter, S.; Ax, F.; Lennernäs, H.; Hallberg, A.; Pettersson, C.; Karlén, A. Hydrogen bonding descriptos in the prediction of human in vivo intestinal permeability. J. Mol. Graphics Modell. 2003, 21, 273-287.
23. Bakken, G. A.; Jurs, P. C. Classification of Multidrug-Resistance Reversal Agents Using Structure-Based Descriptors and Linear Discriminant Analysis. J. Med. Chem. 2000, 43, 4534-4541.
24. Penzotti, J. E.; Lamb, M. L.; Evensen, E.; Grootenhuis, P. D. J. A Computational Ensemble Pharmacophore Model Identifying Substrates of P-Glycoprotein. J. Med. Chem. 2002, 45, 1737-1740.
25. Yoshida, F.; Topliss, J. G. QSAR Model for Drug Human Oral Bioavailability. J. Med. Chem. 2000, 43, 2575-2585.
26. Lee, K.; Ng, C.; Brouwer, K. L. R., Thakker, D. R. Secretory transport of ranitidine and famotidine across caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 2002, 303, 574-580.
27. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991, 175, 880-885.
28. Stewart, B. H.; Chan, O. H.; Lu, R. H.; Reyner, E. L.; Schmid, H. L.; Hamilton, H. W.; Steinbaugh, B. A.; Taylor, M. D. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm Res. 1995, 12, 693-699.
29. Veber, D. F.; Johanson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002, 45, 2615-26.
30. Taub, M. E.; Shen, W.-C. Polarity in the trancytotic processing of apical and basal membrane-bound peroxidase-polylysine conjugates in MDCK cells. J. Cell Physiol. 1992, 150, 283-290
31. Taub, M. E.; Kristensen, L.; Frøkjær, S. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur. J. Pharm. Sci. 2002, 15, 331-340.
32. MOE (Molecular Operating Environment) software available from Chemical Computing Group (www.chemcomp.com).
33. Xu, Y.; Johnson, M. Algorithm for naming molecular equivalence classes represented by labeled pseudographs J. Chem. Inf. Comput. Sci. 2001, 41 (1), 181-185.
34. Definitions taken from UNITY4.2 available from Tripos, Inc. 1699 South Hanley Rd., St. Louis, MO 63144-2319.
35. Ash, S.; Cline, M. A.; Homer, R. W.; Hurst, T.; Smith, G. B. SYBYL line notation (SLN): A versatile language for chemical structure representation. J. Chem. Inf. Comput. Sci. 1997, 37 (1), 71-79.
36. Cheshire is a part of MDL Chemistry Rules Interface available from MDL Information Systems Inc., San Leandro, CA, 94577.
37. Sybyl 6.6 Tripos Associates Inc., 1699 South Hanley Rd., St. Louis, MO 63144.
38. Moriguchi, I.; Hirono, S.; Liu, Q.; Nakagome, I.; Matsushita, Y. Simple Method of Calculating Octanol/Water Partition Coefficient. Chem. Pharm. Bull. 1992, 40, 127-139.
39. Moriguchi, I.; Hirono, S.; Liu, Q.; Nakagome, I.; Hirano, H. Comparison of Reliability of logP Values for Drugs Calculated by Several Methods. Chem. Pharm. Bull. 1994, 42, 976-978.
40. BioByte Corp. 201 W. Fourth St., Suite #204, Claremont, CA 91711-4707.
41. Concord program. Balducci, R.; McGarity, C.; Rusinko, A., III; Skell, J. M.; Smith, K.; Pearlman, R. S. Laboratory for Molecular Graphics and Theoretical Modeling, College of Pharmacy, University of Texas, Austin, TX 78712.
42. SAVol 3.7. Pearlman, R. S.; Skell; J. M.; Deanda, F. Laboratory for Molecular Graphics and Theoretical Modeling, College of Pharmacy, University of Texas, Austin, TX 78712.
43. MatLab, Math Works. Ins., Natick, MA 01760.
44. PLS-Toolbox, Wise & Gallagher, Eigenvector Technologies, Manson, WA 98831.
45. Fielding, A. H.; Bell, J. F. A review of methods for the assessment of prediction errors in conservation presence/absence models. Enviromen. Conserv. 1997, 24, 38-49.
46. Cohen, J. A. A coefficient of agreement for nominal scales. Educ. Psych. Meas. 1960, 20, 37-46.